BNTXBioNTech SE同业对比
BioNTech SE 与iShares Biotechnology ETF 持仓的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:IBB 前十大持仓| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BNTX本股 | $22.8B#13 | — | — | — | — | — | — | — | — | — | -13.5%#10 | — |
| VRTX | $139.2B#4 | 35.3x#4 | 6.7x#4 | 11.6x#7 | 8.9%#8 | 838.1%#3 | 34.8%#2 | 18.9%#5 | 17.4%#6 | — | 30.3%#8 | — |
| AMGN | $258.6B#2 | 27.7x#3 | 18.0x#9 | 7.0x#4 | 10.0%#7 | 88.5%#7 | 24.7%#7 | 53.7%#2 | 14.2%#7 | — | 64.1%#6 | 2.0%#1 |
| GILD | $216.4B#3 | — | 16.6x#7 | 7.3x#5 | 2.4%#9 | 1672.9%#2 | 34.0%#3 | 65.3%#1 | 25.7%#3 | — | 44.4%#7 | 1.9%#2 |
| REGN | — | 20.6x#2 | — | — | 1.0%#11 | 2.1%#10 | 24.9%#6 | 13.4%#6 | 9.2%#9 | — | — | — |
| ARGX | $57.6B#6 | — | — | 1621.8x#12 | 254.4%#1 | 55.1%#8 | 2965.7%#1 | — | — | — | 12.0%#9 | — |
| ALNY | $21.6B#14 | 8.4x#1 | 6.0x#3 | 5.8x#3 | 65.2%#3 | 212.8%#4 | 13.5%#9 | 8.7%#8 | 19.3%#5 | — | -62.0%#11 | — |
| NTRA | $56.3B#7 | — | 30.9x#10 | 24.4x#8 | 35.9%#5 | -9.3%#11 | -13.4%#11 | -11.4%#10 | -18.0%#10 | — | 99.1%#3 | — |
| RVMD | $43.2B#8 | — | 18.0x#8 | — | — | -88.5%#14 | — | -47.1%#12 | — | — | 240.8%#2 | — |
| BIIB | $37.6B#9 | 110.2x#7 | 2.5x#1 | 3.8x#1 | 2.2%#10 | -20.8%#12 | 28.7%#5 | 8.7%#7 | 12.3%#8 | 3#3 | 70.7%#5 | — |
| ILMN | $34.3B#10 | 39.0x#5 | 10.9x#5 | 7.9x#6 | -0.7%#12 | 169.5%#5 | 18.6%#8 | 27.0%#3 | 19.9%#4 | 8#1 | 93.9%#4 | — |
| MRNA | $103.2B#5 | — | 15.3x#6 | 53.1x#10 | -39.9%#13 | 20.8%#9 | -158.1%#12 | -41.7%#11 | -54.6%#11 | — | 988.4%#1 | — |
| INSM | $24.1B#12 | — | 33.2x#11 | 39.8x#9 | 66.7%#2 | -39.7%#13 | -205.6%#13 | -175.8%#13 | -141.2%#12 | 3#3 | — | — |
| ONC | $558.0B#1 | 877.9x#8 | 107.8x#12 | 104.4x#11 | 40.2%#4 | 144.5%#6 | 8.4%#10 | 5.5%#9 | 29.9%#2 | 6#2 | — | — |
| INCY | $25.1B#11 | 62.7x#6 | 4.4x#2 | 4.9x#2 | 21.2%#6 | 3846.9%#1 | 29.5%#4 | 22.8%#4 | 45.1%#1 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-05。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议